WSJ News Exclusive | Merck Explores Purchase of Biotech Seagen

Merck MRK -0.32% & Co. is eyeing a purchase of biotech Seagen Inc., SGEN 12.72% according to people familiar with the matter, a move that would beef up the pharmaceutical giant’s cancer-drug portfolio. Talks have been under way for a while, and a deal isn’t imminent, the people said, cautioning that pulling one off could … Read more

FDA Authorizes First Covid-19 Vaccines for Young Children

Some 1½ years after first authorizing the shots for people of older ages, the Food and Drug Administration on Friday expanded use of the vaccines to the nearly 20 million children in the U.S. from 6 months to under 5 years. A national campaign to vaccinate the young children is expected to kick off as … Read more

WTO Nations Agree to Ease Patent Rights to Boost Covid-19 Vaccine Supplies in Poorer Nations

GENEVA—The member countries of the World Trade Organization agreed Friday on a narrow measure aimed at boosting the supplies of Covid-19 vaccines in developing countries, wrapping up a bitter fight over corporate patent rights governing critical medical products during a pandemic. The compromise measure on intellectual property rights will make it easier for companies in … Read more

Walmart to Raise Wages for Pharmacy Workers

Walmart Inc. WMT 1.04% is raising wages for its pharmacy technicians, a sign that large retail pharmacies continue to compete fiercely for some workers. Starting next week Walmart said it would raise wages for pharmacy technicians to bring average pay for the role to more than $20 an hour. It also promised more frequent wage … Read more

FDA Advisers Review Pfizer, Moderna Covid-19 Vaccines in Young Children

A positive recommendation would likely lead soon to expanding the U.S. Covid-19 vaccination campaign to the 19.6 million children ranging in age from 6 months to under 5 years old, one of the last groups of people in the U.S. waiting for shots. Moderna’s two-dose vaccine is up for the Food and Drug Administration’s authorization … Read more

FDA Should Authorize Moderna’s Vaccine for Ages 6 to 17, Advisers Say

A panel of advisers to the Food and Drug Administration recommended the agency expand use of Moderna Inc.’s Covid-19 vaccine to children ages 6 through 17. The advisory committee voted 22-0 on Tuesday that the benefits of vaccinating children in this age group outweigh the risks. The FDA will consider the vote in making a … Read more

Canada Approves Amylyx’s ALS Drug as U.S. Seeks More Time to Review

Canadian health authorities approved Amylyx Pharmaceuticals Inc.’s new drug for amyotrophic lateral sclerosis, the progressive neurodegenerative disease that robs patients of their ability to move and speak. It is the first Canadian approval since 2018 for a new drug treating the fatal condition, which is also known as Lou Gehrig’s disease. The action by Health … Read more

Three-Dose Pfizer Covid Vaccine Works Safely in Young Children, Review Says

The FDA staff also said, in a review of study data posted online Sunday, that there were no new safety concerns using the vaccine in young children compared with older age groups. The assessment is the latest sign that authorities are moving closer to clearing inoculations for children under 5 years old, the last group … Read more

The Billionaire Funding a Battle Against Hospital Monopolies

John Arnold antagonized public-employee unions and pharmaceutical firms with campaigns to reform government-funded pensions and bring down high drug prices. Now the Texas billionaire has a new foe: big-hospital monopolies. A philanthropic organization founded by the ex-energy trader and his wife Laura is providing financial backing to three lawsuits against giant hospital systems in Wisconsin, … Read more

Moderna’s Covid-19 Vaccine Works Safely in Kids, Including Those Under Age 5, FDA Says

Moderna Inc.’s Covid-19 vaccine was effective at preventing symptomatic disease in children ages 6 months through 5 years, Food and Drug Administration staff said in a review of the evidence. The FDA staff also said Friday that Moderna’s vaccine was generally safe in children in studies, including those under 5 years who haven’t had access … Read more